Rostil 250 mg venous circulation insufficiency, 30 tablets
 
 
Rostil is a drug containing calcium dobesate, supporting the proper functioning of capillaries and veins. It seals blood vessels and has an anti-swelling effect.
 
Indications
Treatment of symptoms of chronic venous insufficiency of the lower extremities (pain, cramps, tingling, swelling, skin changes due to blood stagnation).
 
Action
Rostil is a drug in the form of tablets. It contains the active substance calcium, dobesylate monohydrate, which acts on the capillary epithelium, vein walls and lymphatic vessels. The drug reduces the permeability of capillaries, increases their strength, prevents the formation of exudates and improves microcirculation.
It increases the tension of the vein wall, preventing blood stagnation and the formation of blood clots. It intensifies collagen synthesis, reduces plasma viscosity, increasing its flow through peripheral tissues.
It works to seal the vessels within the lymphatic system, reducing swelling, which leads to pain relief and a feeling of heaviness in the limbs.
 
Contraindications
Do not use the drug:
if you are allergic to the active substance or any of the other ingredients of this medicine,
for pregnant and lactating women.
 
Talk to your doctor or pharmacist before taking Rostil:
if you have severe kidney failure
if you suffer from chronic recurrent catarrhal gastritis,
if you have a stomach ulcer and / or duodenal ulcer.
 
Receiving
Always use this medicine exactly as described in the package leaflet or as directed by your doctor or pharmacist. Check with your doctor or pharmacist if you are not sure.
Oral drug.
Recommended dose
Symptomatic treatment of chronic venous insufficiency of the lower limbs
Adults from 500 mg (2 tablets) to 1000 mg (4 tablets) daily.
The drug should be taken with a meal.
Duration of treatment
Symptomatic treatment of chronic venous insufficiency of the lower limbs
Treatment may last from several weeks to several months.
 
Interactions
Tell the doctor or pharmacist about all the drugs taken by the patient now or recently, as well as about the drugs that the patient plans to take.
There are no data on the interaction of calcium dobesilate with other drugs.
 
Ingredients
The active substance is calcium dobesilate monohydrate (one tablet contains 250 mg of calcium dobesilate monohydrate).
The other ingredients are: Lactose monohydrate, Potato starch, Microcrystalline cellulose, Talc, Colloidal anhydrous silica, Sodium laurilsulfate, Magnesium stearate, Crospovidone.